News & Media

Monteris Medical Announces $13 Million Financing

PLYMOUTH, Minn. & WINNIPEG, Manitoba--(BUSINESS WIRE)--Monteris Medical Inc. (Monteris) announced it has closed financing totaling $13.3 million ($8.3 million preferred share component and $5 million of term debt) to support the commercialization of the NeuroBlate System® in the North American neurosurgery market. With this latest financing round total capital raised in 2012 and 2013 exceeds $30 million. BDC Venture Capital led the preferred share round, with the remainder funded by the SWMF Life Science Fund and other independent parties. Oxford Finance LLC (“Oxford”) provided the term debt.

Click here for the article.

Back

Subscribe to the BAM Newsletter

Sign up for one of BAM's newsletter to learn more about bioscience, happenings in Manitoba's bioeconomy, industry conferences, and BAM training events.

Subscribe